GSM8262979: N3; Homo sapiens; RNA-Seq
A total of 26 blood and serum samples were collected from hospitalized children with CHD in the Dalian Children's Hospital. Blood samples were used for transcriptomic analysis and serum samples were used for metabolomics analysis. Blood and serum samples were collected 24 hours before discharge from the hospital (or after surgery). The children with CHD were divided into three groups according to the nutritional risk and neurodevelopmental status: low nutritional risk combined with normal neurodevelopment (n=14, group A), low nutritional risk combined with neurodevelopmental disorders (n=5, group B), high nutritional risk combined with normal neurodevelopment (n=7, group C). Total RNA was extracted from the samples with TRIzol. Sequencing By Synthesis (SBS) technology was used to sequence the cDNA library using Illumina's high-throughput sequencing platform.